Phyxiom

Phyxiom™ is a clinically proven digital platform that enables clinicians to provide more accurate diagnosis and precision treatment to patients with uncontrolled Asthma. Phyxiom™ is a spin-out from the Royal College of Surgeons in Ireland (RCSI). Our technology is the result of over 12 years’ of clinical research and multiple randomised control trials developing a family of patented algorithms and software platforms for the management of chronic respiratory disease. Our mission is to replicate these better outcomes for the 540 million patients globally with either COPD or Asthma. Our evidence-based approach has demonstrated results of 30% cost saving through accurate diagnosis, 20% reduction in steroid burden and 60% reduction in step-up treatment. Using data-driven insight and trend analysis, we give clinicians a perspective of personalised patient care. Designed by clinicians, for clinicians, our business model ensures seamless integration to the clinicians existing systems and processes with minimum disruption.